​

Funding Round

Post-IPO Equity - InterCure

Post-IPO Equity - InterCure

Investment Firm

Overview

InterCure is a medical device company focused on respiratory treatment that has developed and patented a technology platform.

Announced Date

Nov 01, 2018

Funding Type

Post Ipo Equity

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

GMF Capital

GMF Capital

GMF Capital is a early_stage_venture and post_ipo and private_equity and seed firm.

Participant Investors

2

Investor Name
Participant InvestorGMF Capital
Participant InvestorAdam Neumann

Round Details and Background

InterCure raised $17500000 on 2018-11-01 in Post-IPO Equity

InterCure is a medical device company focused on respiratory treatment that has developed and patented a technology platform.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 02, 2001
Venture Round - InterCure
-3.5M
Mar 29, 2000
Series A - InterCure
2-5.4M
Apr 13, 2005
Series C - InterCure
2-3.0M
Oct 30, 2001
Series B - InterCure
6-4.5M

Recent Activity

There is no recent news or activity for this profile.